Association between C-Maf-inducing protein gene rs2287112 polymorphism and schizophrenia

PeerJ. 2021 Aug 20:9:e11907. doi: 10.7717/peerj.11907. eCollection 2021.

Abstract

Background: Schizophrenia is a severely multifactorial neuropsychiatric disorder, and the majority of cases are due to genetic variations. In this study, we evaluated the genetic association between the C-Maf-inducing protein (CMIP) gene and schizophrenia in the Han Chinese population.

Methods: In this case-control study, 761 schizophrenia patients and 775 healthy controls were recruited. Tag single-nucleotide polymorphisms (SNPs; rs12925980, rs2287112, rs3751859 and rs77700579) from the CMIP gene were genotyped via matrix-assisted laser desorption/ionization time of flight mass spectrometry. We used logistic regression to estimate the associations between the genotypes/alleles of each SNP and schizophrenia in males and females, respectively. The in-depth link between CMIP and schizophrenia was explored through linkage disequilibrium (LD) and further haplotype analyses. False discovery rate correction was utilized to control for Type I errors caused by multiple comparisons.

Results: There was a significant difference in rs287112 allele frequencies between female schizophrenia patients and healthy controls after adjusting for multiple comparisons (χ2 = 12.296, P adj = 0.008). Females carrying minor allele G had 4.445 times higher risk of schizophrenia compared with people who carried the T allele (OR = 4.445, 95% CI [1.788-11.046]). Linkage-disequilibrium was not observed in the subjects, and people with haplotype TTGT of rs12925980-rs2287112-rs3751859-rs77700579 had a lower risk of schizophrenia (OR = 0.42, 95% CI [0.19-0.94]) when compared with CTGA haplotypes. However, the association did not survive false discovery rate correction.

Conclusion: This study identified a potential CMIP variant that may confer schizophrenia risk in the female Han Chinese population.

Keywords: C-Maf-inducing protein; CMIP; Gene polymorphism; Haplotype analysis; Schizophrenia.

Grants and funding

This work was supported by the National Natural Science Foundation of China (No. 81673253) and the Youth Development Fund from First Hospital of Jilin University (No. JDYY11202021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.